VRTX

VRTX: To Present At Thomas Weisel Healthcare Conference @ 08:00 ET [delayed] - 09/03 - 07:24 AM ET

Vertex Pharmaceuticals Announces Webcast of its Presentation at the Thomas Weisel Partners Healthcare Conference 2008 - 08/29 - 09:15 AM ET

Vertex Pharmaceuticals (VRTX) NewsBite - VRTX Could Be On the Move - 08/28 - 12:12 PM ET

Vertex Pharmaceuticals Accelerates To Weekly High - 08/26 - 10:08 AM ET

Vertex Pharmaceuticals Drops To 3-Week Low - 08/20 - 01:40 PM ET

Vertex to initiate Phase III study of hepatitis drug - 08/20 - 12:01 PM ET

Vertex Pharmaceuticals (VRTX) NewsBite - One Of Today's Top Losers So Far - 08/20 - 03:49 AM ET

CORRECT: Vertex Pharma to begin Phase III trial - 08/19 - 08:23 AM ET

Vertex Pharma in deal with U.S. and European regulators to begin Phase III trial - 08/19 - 07:50 AM ET

Vertex Pharmaceuticals to Start Phase 3 'REALIZE' Trial with Telaprevir in Treatment-Failure HCV Patients - 08/19 - 07:30 AM ET

Vertex Pharmaceuticals Breaks Support - 08/18 - 03:10 PM ET

VRTX: To Present At Canaccord Adams Global Growth Conference @ 08:30 ET [delayed] - 08/13 - 07:53 AM ET

Vertex Pharmaceuticals Announces Webcast of its Presentation at the Canaccord Adams 28th Annual Global Growth Conference - 08/08 - 04:15 PM ET

Vertex Pharmaceuticals Picks Up Volume, Extends Losses - 08/07 - 03:46 PM ET

VRTX: To Present At BMO Focus on Healthcare Conference @ 09:00 ET [delayed] - 08/06 - 07:38 AM ET

VRTX: To Present At IBC Life Sciences DDT 2008 Conference @ 11:30 ET [delayed] - 08/05 - 09:53 AM ET

VRTX: To Present At IBC Life Sciences DDT 2008 Conference @ 11:15 ET [delayed] - 08/05 - 09:53 AM ET

Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2008 BMO Capital Markets Focus on Healthcare Conference - 08/05 - 09:43 AM ET

Vertex Pharmaceuticals Highlights Telaprevir Progress and Reports Second Quarter 2008 Results - 07/31 - 04:17 PM ET

VRTX: Q2 Earnings Call @ 17:00 ET Today [delayed] - 07/31 - 02:23 PM ET

Page 1 of 11 1 2 3 4 5 > >>| Previous | Next

<< Back to Stock Index

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.